Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $164.83 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $85.39 | 2 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $35.25 | 2 | $0 (2017) |
| Braeburn Pharmaceuticals, Inc. | $16.20 | 1 | $0 (2017) |
| Allergan Inc. | $15.06 | 1 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $12.93 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $65.06 | 1 | Alkermes, Inc. ($65.06) |
| 2018 | $20.33 | 1 | Alkermes, Inc. ($20.33) |
| 2017 | $79.44 | 5 | Vanda Pharmaceuticals Inc. ($35.25) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/06/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $65.06 | General |
| Category: CNS | ||||||
| 01/10/2018 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: CNS | ||||||
| 10/19/2017 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Schizophrenia | ||||||
| 09/21/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: PSYCHIATRY | ||||||
| 07/13/2017 | Vanda Pharmaceuticals Inc. | Fanapt (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Schizophrenia | ||||||
| 06/22/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2017 | Braeburn Pharmaceuticals, Inc. | Probuphine (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Opioid addiction | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 126 | 133 | $42,427 | $10,698 |
| 2021 | 3 | 224 | 247 | $82,475 | $24,009 |
| 2020 | 5 | 182 | 200 | $60,754 | $15,906 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 133 | $42,427 | $10,698 | 25.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 175 | 198 | $63,162 | $19,662 | 31.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 38 | 38 | $19,038 | $4,281 | 22.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 11 | 11 | $275.00 | $66.30 | 24.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 93 | 104 | $31,655 | $8,337 | 26.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 42 | 42 | $21,042 | $5,562 | 26.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 19 | 19 | $6,327 | $1,648 | 26.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 12 | $1,500 | $290.35 | 19.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 17 | 23 | $230.00 | $67.86 | 29.5% |
About Dr. Farzad Sarmast, MD
Dr. Farzad Sarmast, MD is a Emergency Medicine healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104014422.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Farzad Sarmast, MD has received a total of $164.83 in payments from pharmaceutical and medical device companies, with $65.06 received in 2019. These payments were reported across 7 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($164.83).
As a Medicare-enrolled provider, Sarmast has provided services to 532 Medicare beneficiaries, totaling 580 services with total Medicare billing of $50,613. Data is available for 3 years (2020–2022), covering 9 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Family Medicine
- Location Syracuse, NY
- Active Since 10/11/2007
- Last Updated 01/12/2017
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1104014422
Products in Payments
- ARISTADA (Drug) $65.06
- Fanapt (Drug) $35.25
- Vivitrol 380 mg (Drug) $20.33
- Probuphine (Drug) $16.20
- VRAYLAR (Drug) $15.06
- ABILIFY MAINTENA (Drug) $12.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Syracuse
David Mason, Md, MD
Emergency Medicine — Payments: $1,580
Ross Sullivan, Md, MD
Emergency Medicine — Payments: $1,510
Fouad Boulos, Md, MD
Emergency Medicine — Payments: $878.53
Mark Stever, Rpa, RPA
Emergency Medicine — Payments: $860.86
Kevin Stimson, M.d, M.D
Emergency Medicine — Payments: $546.44
Richard Steinmann, Md, MD
Emergency Medicine — Payments: $544.35